Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mazen M. Gad"'
Activating mutations in the EGFR kinase domain are known to be a common cause of Non-Small Cell Lung Cancer (NSCLC) and are thus targeted for treatment. First generation Tyrosine Kinase Inhibitors (TKIs) were used to treat NSCLC patients with the kno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f3f53b39899433ef44c9a5e442ea26
